drugset / Trial / NCT00358280

Ropivacaine Versus Bupivacaine for Spinal Anaesthesia in Patients Undergoing Unilateral Lower Limb Surgery

NCT00358280

Phase 3 Completed 220 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the efficacy, duration of motor block until return to normal function in the non-operated leg after the start of injection, of ropivacaine 5 mg/ml and bupivacaine 5 mg/ml when used for spinal anaesthesia in patients undergoing unilateral lower limb surgery.

Timeline

Start
2006-04
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 5 mg/ml
Subject Ropivacaine Other / unclassified 5 mg/ml

Indications

No indication recorded.